GlaxoSmithKline plc (the 'Company')
Transaction notification
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Dr M M Slaoui
b)
Position/status
Chairman, Global Vaccines
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
GlaxoSmithKline plc
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
Description of the financial instrument
American Depositary Shares ('ADSs')
ISIN: US37733W1053
Nature of the transaction
Acquisition of ADSs following the re-investment of dividends paid to shareholders on 13 October 2016 on ADSs held in the Company's US Deferred Performance Plan.
Price(s) and
volume(s)
Price(s)
Volume(s)
$46.1526
244.955
d)
Aggregated information
Aggregated volume Price
n/a (single transaction)
e)
Date of the transaction
2016-10-13
f)
Place of the transaction
New York Stock Exchange (XNYS)
Mr D E Troy
SVP & General Counsel
Acquisition of ADSs following the re-investment of dividends paid to shareholders on 13 October 2016 on ADSs held in the Company's US Deferred Performance Share Plan.
324.557
5.002
329.559